Viatris Inc.(VTRS)公司股价今日盘中暴跌20.73%,引发市场广泛关注。公司股价大幅走低的主要原因来自以下两个方面:
首先,Viatris公司2024年第四季度的财报数据出现了不尽理想的表现。公司调整后每股收益为0.54美元,低于分析师一致预期的0.57美元;季度营收为35.2亿美元,也未达到36.1亿美元的预期水平。同时,公司营收和每股收益数据也较上年同期出现了下滑。财报疲软表现令投资者对公司未来增长前景感到失望,带动了股价的大幅下跌。
此外,早些时候美国FDA针对Viatris在印度印多尔的工厂实施进口限制措施,也给公司今年的业务发展带来了不利影响。Viatris预计FDA的行动将减少公司2025年的收入约5亿美元,调整后核心利润也将减少约3.85亿美元。监管部门措施加剧了市场对公司增长前景的担忧,进一步推动了股价的暴跌走势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.